[Successful gamma globulin therapy in a patient with anti-IgA antibodies].
A case report of a patient suffering from common variable immunodeficiency with anti-IgA antibodies is described. These antibodies were probably the cause of repeated anaphylactic reactions during substitution gammaglobulin treatment, and lead to discontinuation the therapy lasting 4 years. The reintroduction the therapy was enabled by the therapy with low-IgA contents intravenous immunoglobulin (Endobulin, Immuno Vienna).
Litzman
J
J
Ustav klinické immunologie lékarské fakulty Masarykovy university, FN U sv. Anny, Brno.
Broz
P
P
Král
V
V
Lokaj
J
J
D000888:Antibodies, Anti-Idiotypic / Q000032:analysis*; D017074:Common Variable Immunodeficiency / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007070:Immunoglobulin A; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D000888:Antibodies, Anti-Idiotypic; D007070:Immunoglobulin A; D016756:Immunoglobulins, Intravenous
Uspĕsná gamaglobulinová lécba u nemocného s anti-IgA protilátkami.